To further evaluate this premise, it was also reported that expression of HCP5 and ST6GAL2 was even higher in cell lines that represent more invasive FTC when compared to cells that represent poorly invasive FTC. This evidence concerns the gene ST6GAL2 and thyroid cancer, nonmedullary, 2.